Stark, Shauna
Stark, Craig
Wong, Brian
Brin, Mitchell F.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning
https://doi.org/10.1038/s41598-023-29280-x
Funding for this research was provided by:
Allergan, an AbbVie company (ITT-00972, ITT-00972)
Article History
Received: 25 August 2022
Accepted: 1 February 2023
First Online: 27 February 2023
Competing interests
: This study was sponsored by a grant from Allergan, an AbbVie Company (grant number ITT-00972), awarded to Dr. Craig Stark. Dr. Mitchell Brin, an author on this study, is an employee of AbbVie, and receives stock or stock options in AbbVie. The other authors have no competing interests.